Vancouver, Canada

Bradley John Hedberg

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 7.6

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Vancouver, CA (2012 - 2023)
  • Sooke, CA (2020 - 2024)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Bradley John Hedberg

Introduction

Bradley John Hedberg is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with cytotoxic and anti-mitotic properties. With a total of nine patents to his name, Hedberg's work has the potential to impact cancer treatment and diagnosis.

Latest Patents

Hedberg's latest patents include "Cytotoxic and anti-mitotic compounds, and methods of using the same." This patent discloses compounds that exhibit cytotoxic and/or anti-mitotic activity, along with methods for their preparation and use. Additionally, it covers pharmaceutical compositions that incorporate these compounds. Another significant patent is "Anti-podocalyxin antibodies and methods of using the same," which focuses on antibodies that can be used for the prevention, diagnosis, and treatment of cancer.

Career Highlights

Throughout his career, Hedberg has worked with various companies, including Zymeworks Inc. His expertise in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health challenges.

Collaborations

Hedberg has collaborated with notable professionals in his field, including John Stephen Babcook and Geoffrey C Winters. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Bradley John Hedberg's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing cancer treatment. His work continues to inspire future research and development in this vital area of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…